Nausea Medicine Market Analysis By Type (antihistamines, dopamine antagonists, serotonin antagonists, prokinetic agents, and others), By Route of Administration (oral, parenteral (intravenous, intramuscular, subcutaneous), rectal, and transdermal), By Distribution Channel (hospitals, clinics, retail pharmacies, and online pharmacies), By Application (chemotherapy-induced nausea and vomiting, postoperative nausea and vomiting, motion sickness, pregnancy-related nausea and vomiting, and others) & Forecast 2024-2035
- PUBLISHED ON
- 4/14/2023
- NO OF PAGES
- 283
- CATEGORY
- Healthcare & Life Sciences
The nausea medicine market is a rapidly growing segment of the pharmaceutical industry. Nausea is a common symptom associated with a variety of medical conditions and treatments, such as chemotherapy, surgery, and pregnancy. Nausea medicines are used to alleviate or prevent nausea and vomiting.
The global nausea medicine market is expected to continue to grow in the coming years due to factors such as the increasing prevalence of nausea associated with chemotherapy and the growing number of people undergoing surgery. Additionally, the development of new and more effective nausea medicines is expected to further drive the growth of the market.
One of the key drivers of the market is the use of nausea medicines in chemotherapy patients. Chemotherapy-induced nausea and vomiting (CINV) is a common and distressing side effect of cancer treatment. The use of antiemetic drugs, such as 5-HT3 receptor antagonists, NK1 receptor antagonists, and corticosteroids, has been shown to be effective in preventing and treating CINV.
The market for nausea medicines is dominated by a few key players, including GlaxoSmithKline plc, Sanofi S.A., F. Hoffmann-La Roche AG, and Pfizer Inc. The market is expected to continue to grow in the coming years, driven by factors such as the increasing prevalence of nausea and the development of new and more effective treatments.
Segment Overview
The nausea medicine market can be segmented in several ways, including:
1. By Type: Nausea medicines can be classified into different types based on their mode of action, such as antihistamines, dopamine antagonists, serotonin antagonists, prokinetic agents, and others.
2. By Route of Administration: Nausea medicines can be administered through different routes such as oral, parenteral (intravenous, intramuscular, subcutaneous), rectal, and transdermal.
3. By Distribution Channel: Nausea medicines can be sold through different channels such as hospitals, clinics, retail pharmacies, and online pharmacies.
4. By Application: Nausea medicines can be used for various applications such as chemotherapy-induced nausea and vomiting, postoperative nausea and vomiting, motion sickness, pregnancy-related nausea and vomiting, and others.
5. By Geography: The market can be segmented by geography, such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Geographical Overview
The market for nausea medicine is a global one, with demand for these medications present in almost every country in the world. The top markets for nausea medicine include North America, Europe, Asia-Pacific, and the Middle East and Africa.
North America is the largest market for nausea medicine, driven by the high incidence of nausea-related conditions such as chemotherapy-induced nausea and vomiting (CINV), postoperative nausea and vomiting (PONV), and motion sickness. The United States is the largest market in this region, accounting for a significant portion of the global market share.
Europe is the second-largest market for nausea medicine, with a significant portion of demand coming from countries such as Germany, France, and the United Kingdom. The growing prevalence of cancer and gastrointestinal diseases in this region is driving demand for these medications.
The Asia-Pacific region is expected to see significant growth in the coming years, driven by the rising incidence of nausea-related conditions in countries such as China and India. The increasing adoption of western lifestyles and diets is also contributing to the growth of the market in this region.
The Middle East and Africa are also expected to see growth in the market for nausea medicine, driven by the rising incidence of nausea-related conditions such as gastroenteritis, hepatitis, and HIV/AIDS.
Overall, the global market for nausea medicine is expected to continue to grow in the coming years, driven by the increasing incidence of nausea-related conditions, the growing aging population, and the increasing adoption of western lifestyles and diets.
COVID Impact
The COVID-19 pandemic has had a significant impact on the nausea medicine market. The pandemic has resulted in a surge in demand for nausea medicine as a side effect of COVID-19 is nausea and vomiting. Additionally, the pandemic has also led to an increase in anxiety and stress, which can also cause nausea. As a result, many individuals have been seeking medication to help alleviate their symptoms.
On the other hand, the pandemic has also disrupted the supply chain of many drugs, including nausea medicine, due to lockdowns, travel restrictions, and other measures taken to contain the spread of the virus. This has led to shortages of some types of nausea medicine, which has further fueled the demand for alternative medications.
The COVID-19 pandemic has also brought about changes in healthcare delivery, with an increased focus on telemedicine and remote consultations. This has impacted the way nausea medicine is prescribed and distributed, with many healthcare providers opting to prescribe medication remotely instead of in-person consultations.
In summary, while the COVID-19 pandemic has increased demand for nausea medicine, it has also disrupted the supply chain and delivery of medication, leading to shortages in some cases. The long-term impact of the pandemic on the nausea medicine market remains to be seen, and will likely depend on the course of the pandemic and the effectiveness of measures taken to mitigate its impact.
Competitive Analysis
The global nausea medicine market is highly competitive, with several large players and numerous small players operating in the market. The key players in the market include GlaxoSmithKline, Pfizer, Sanofi, Johnson & Johnson, Merck & Co., Novartis, Teva Pharmaceutical Industries Ltd., Procter & Gamble Co., Bayer AG, and Eli Lilly and Company.
The market is primarily driven by factors such as the increasing prevalence of nausea and vomiting, the growing demand for effective and safe medications, and the increasing healthcare expenditure. Additionally, the increasing adoption of combination therapies and the rising awareness about the side effects associated with antiemetic drugs are also driving the market growth.
The market is characterized by intense competition, with the leading players competing on the basis of product innovation, quality, price, and distribution. These players are also focusing on mergers, acquisitions, and partnerships to expand their product portfolio and geographical reach.
In recent years, there has been a significant increase in the number of mergers and acquisitions in the market, with companies seeking to expand their product portfolio and increase their market share. For instance, in 2018, GlaxoSmithKline acquired Tesaro Inc., a company that develops cancer treatments, to expand its oncology portfolio.
In terms of regional analysis, North America dominates the market, followed by Europe and the Asia Pacific. The market in North America is driven by the increasing prevalence of nausea and vomiting, the growing demand for effective and safe medications, and the presence of key players in the region.
Overall, the nausea medicine market is highly competitive, with several large players and numerous small players operating in the market. The market is expected to witness significant growth in the coming years, driven by factors such as the increasing prevalence of nausea and vomiting and the rising awareness about the side effects associated with antiemetic drugs.
Historic Year: 2016-2022
Forecast: 2024-2035
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $4250
Only Four Thousand Two Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $5250
Only Five Thousand Two Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $6250
Only Six Thousand Two Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI